Dhan Chand

8PUBLICATIONS
121CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2026
Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.

|Jun 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses.

|Jun 15, 2026
Transcriptomic profiling identifies immunotherapy-responsive phenotypes in microsatellite-stable metastatic colorectal cancer.

|Dec 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.

Rebecca Porter, Bruno Bockorny, Bradley R Corr

|Nov 19, 2025
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling.

Carlos O Ontiveros, Myrna G Garcia, Clare E Murray

|Nov 14, 2025
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity.

Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet

Pageof 2

Frequent Collaborators

3 joint publications

Tyler J Curiel

3 joint publications

Joseph E Grossman

3 joint publications

Chloe Delepine

3 joint publications

Kah Teong Soh